Abstract
Background: Azodicarbonamide is a dough-enhancer used in the process of breadmaking in countries like Nigeria. While there have been suggestions that it is a sensitizer of the respiratory system, there is a dearth of information on its effects on the central nervous system.
Aim: This study assessed the effects of azodicarbonamide on the central nervous system (ADA) in rats.
Objective: The effects of ADA-containing diet on neurobehaviour, brain antioxidant status, and neuromorphology of selected brain regions in rats were examined.
Methods: Forty adult rats were randomly-assigned into four groups of ten rats each, and were given standard diet or diet containing ADA at 1, 2 and 4% respectively. Rats were fed a standard diet or ADA-containing diet for a period of 28 days. Weekly body weight assessment and daily estimation of food intake were done. Behavioural tests {in the Open field, Y-maze, radial-arm maze, and Elevated Plus Maze (EPM)} were conducted on day 29. Twenty-four hours after the last behavioural test, animals were euthanised, whole brains were dissected, weighed, and either homogenised for assessment of lipid peroxidation and antioxidant status; or sectioned and processed for general histology.
Results: Consumption of ADA-containing diet was associated with a significant decrease in weight gain/food intake, and significant suppression of horizontal locomotion and rearing behaviours; however, grooming activity increased significantly. Also, there was a significant reduction of open-arm time in the EPM and a significant increase in Y-maze alternation (at the lowest concentration of ADA). ADA-containing diet was not associated with significant changes in brain oxidative status or neuromorphology.
Conclusion: The study showed that while ADA-containing diet may alter neurobehaviour in rats; this was not associated with evidence of brain oxidative stress or neuro-histomorphological alterations.
Keywords: Dough enhancer, food additive, neurobehaviour, oxidative stress, neuromorphology, central inhibition.
Graphical Abstract
[http://dx.doi.org/10.1016/j.pathophys.2018.04.002] [PMID: 29673924]
[http://dx.doi.org/10.5772/54423.7/47]
[http://dx.doi.org/10.1111/1541-4337.12066]
[http://dx.doi.org/10.1210/jcem-32-5-659] [PMID: 4102820]
[http://dx.doi.org/10.1002/9781118792001.ch10]
[http://dx.doi.org/10.1016/j.nlm.2016.12.021] [PMID: 28049023]
[http://dx.doi.org/10.1016/j.jchemneu.2017.09.001] [PMID: 28890110]
[http://dx.doi.org/10.1016/j.biopha.2016.11.033] [PMID: 27889232]
[http://dx.doi.org/10.1016/j.biopha.2017.05.094] [PMID: 28554133]
[http://dx.doi.org/10.3934/Neuroscience.2016.3.317]
[http://dx.doi.org/10.13189/ijnbs.2016.040201]
[http://dx.doi.org/10.5455/annalsmedres.2018.06.118]
[http://dx.doi.org/10.1016/j.jchemneu.2018.12.002] [PMID: 30529750]
[http://dx.doi.org/10.1016/j.jchemneu.2016.08.006] [PMID: 27565676]
[http://dx.doi.org/10.1016/0041-008X(65)90146-8] [PMID: 14288817]
[http://dx.doi.org/10.1016/0272-0590(90)90057-Q] [PMID: 2227158]
[http://dx.doi.org/10.1037/h0077771] [PMID: 7229159]
[http://dx.doi.org/10.1037/h0041348] [PMID: 13937025]
[http://dx.doi.org/10.1016/j.fct.2008.12.003] [PMID: 19110027]
[http://dx.doi.org/10.1101/lm.32200] [PMID: 11040261]